; Lateral Flow Assays Market Growth, Industry Share, Forecast, 2030

Lateral Flow Assays Market

Lateral Flow Assays Market Global Industry Analyses 2016-2020 an opportunity forecasted 2020-2030

Published on: Jul-2021
Report Code: FG HC 00830
No. of Pages: 178
Report Format: PDF

Market Overview

Lateral flow assays are devices that may be used to confirm the presence or absence of a target analyte without using lab equipment. For the qualitative and quantitative detection of particular antigens and antibodies, these instruments are frequently employed in hospitals and clinical laboratories. It's a low-cost, straightforward method for detecting infections or biomarkers in humans and animals, as well as pollutants and harmful substances in water, food, and animal feed. The COVID-19 pandemic has had a beneficial influence on the lateral flow assays market, since the requirement for quick identification of coronavirus infection has been a priority since the epidemic began in December 2019. As the number of cases has grown across the globe, most of the major lateral flow assay market players have invested in research and development, and formed partnerships and agreements with other market players and government agencies to develop lateral flow diagnostic solutions for the disease. As a result, several COVID-19 antibody and antigen tests have been launched, with excess manufacturing and distribution of these tests across areas to meet increased demand.

Lateral Flow Assays Market: Key Players
  • Abbott Laboratories (U.S.)

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Danaher Corporation (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Siemens Healthineers AG (Germany)
  • Becton, Dickinson and Company (U.S.)
  • BioMérieux SA (France)
  • Bio-Rad Laboratories Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • QIAGEN N.V. (Germany)
  • PerkinElmer Inc. (U.S.)
  • Quidel Corporation (U.S.)
  • Merck KGAA (Germany)


Growth Factor

High prevalence of infectious diseases across the globe

Despite tremendous advancements in sanitation and medicine, infectious illness incidence remains high over the world. Infectious illnesses are still a major public health problem across the world, despite the fact that non-communicable illnesses are the largest cause of morbidity and mortality. Infectious illnesses take the lives of more than 15 million people worldwide each year, according to the National Institute of Allergy and Infectious Diseases. In the forecast period, this factor is expected to be a significant driver of the lateral flow assays market.

  • By Product
    • Kits & Reagents
    • Lateral Flow Readers
    • Digital/Mobile Readers
    • Benchtop Readers
  • By Technique
    • Sandwich Assays
    • Competitive Assays
    • Multiplex Detection Assays
  • By Application
    • Clinical Testing
    • Infectious Disease Testing
    • Cardiac Marker Testing
    • Pregnancy & Fertility Testing
    • Cholesterol Testing/Lipid Profile
    • Drug Abuse Testing
    • Other Clinical Tests
    • Veterinary Diagnostics
    • Food Safety & Environment Testing
    • Drug Development & Quality Testing
  • By End-User
    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Home Care
    • Pharmaceutical & Biotechnology Companies
    • Other End Users
  • Lateral Flow Assays Market Dynamics
  • Lateral Flow Assays Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints


Recent News Related to Market
  1. In September 2020, the PanBio COVID-19 immunochromatographic test for quick qualitative identification of Sars-CoV-2 virus was introduced in Europe by Abbott Laboratories (US).

  2. In September 2020, F.Hoffman La Roche Ltd. (Switzerland) will offer the SARS CoV-2 Rapid Antigen Test in markets that accept the CE Mark.


The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

  • COVID-19 pre and post business impact analysis
  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • What is the Lateral Flow Assays Market growth?
  • Which segment accounted for the largest Lateral Flow Assays Market share?
  • Who are the key players in the Lateral Flow Assays Market?
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint


Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Select License Type


Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555

Select License Type


Report accessible by 1 user only

Sample Request

Client Testimonials